Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

VU0359595

Cat. No.: IBDI-434918

VU0359595 (CID-53361951; ML-270) is a potent and selective pharmacological phospholipase D1 (PLD1) inhibitor with an IC50 of 3.7 nM. VU0359595 is >1700-fold selective for PLD1 over PLD2 (IC50 of 6.4 μM). VU0359595 can be used for the research of cancer, diabetes, neurodegenerative and inflammatory diseases.

Size (Solid):

Product Details

Target Phospholipase | Fungal
Molecular Weight 497.43
Appearance Solid
Synonyms CID-53361951, ML-270
SMILES O=C([[email protected]]1[[email protected]](C2=CC=CC=C2)C1)N[[email protected]@H](C)CN3CCC(N4C5=CC=C(Br)C=C5NC4=O)CC3
Purity 99.65%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.